Laboratorios RichmondC.I.F Balance Sheet Health
Financial Health criteria checks 2/6
Laboratorios RichmondC.I.F has a total shareholder equity of ARS49.8B and total debt of ARS110.4B, which brings its debt-to-equity ratio to 221.5%. Its total assets and total liabilities are ARS212.1B and ARS162.3B respectively. Laboratorios RichmondC.I.F's EBIT is ARS6.6B making its interest coverage ratio 4.7. It has cash and short-term investments of ARS1.8B.
Key information
221.5%
Debt to equity ratio
AR$110.37b
Debt
| Interest coverage ratio | 4.7x |
| Cash | AR$1.84b |
| Equity | AR$49.84b |
| Total liabilities | AR$162.26b |
| Total assets | AR$212.09b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RICHD's short term assets (ARS45.3B) exceed its short term liabilities (ARS40.6B).
Long Term Liabilities: RICHD's short term assets (ARS45.3B) do not cover its long term liabilities (ARS121.7B).
Debt to Equity History and Analysis
Debt Level: RICHD's net debt to equity ratio (217.8%) is considered high.
Reducing Debt: RICHD's debt to equity ratio has increased from 36.4% to 221.5% over the past 5 years.
Debt Coverage: RICHD's debt is not well covered by operating cash flow (1.3%).
Interest Coverage: RICHD's interest payments on its debt are well covered by EBIT (4.7x coverage).